Cancer stem cell marker also drives transcription in normal cells

User rating: 4.5 / 5 after 2 vote(s)

New research links the recently discovered function of a multi-faceted transcriptional complex to control of gene expression in both normal cells and cancer stem cells. Two separate studies, published by Cell Press in the January 18th issue of Molecular Cell, provide insight into novel subunits associated with an evolutionarily conserved transcriptional regulatory complex and reveal a previously undescribed chromatin function that is required for full activity of nuclear receptors in normal cells and for the MYC oncoprotein in tumor cells.


Full story »

All News summaries from Medicine & Health news
All News summaries for January 17, 2008

Briton fuming over fine for smoking in own van

6 hours ago | User rating: not rated yet
A painter and decorator has been fined for breaching Britain's smoking ban -- by puffing on a cigarette in his own van, he said Friday.

Surgical Instrument Size Studied

6 hours ago | User rating: not rated yet
The concept of one size fits all works with many things—smocks, baseball caps and inner tubes. But not disposable laparoscopic surgical instruments.

Hip Bone Density Helps Predict Breast Cancer Risk

6 hours ago | User rating: not rated yet
Measuring a woman’s bone mineral density can provide additional information that may help more accurately determine a woman’s risk of developing breast cancer. That is the conclusion of a new study published in the September ...

Overweight elderly Americans contribute to financial burdens of the US health care system

7 hours ago | User rating: not rated yet
Being overweight or obese is not only a personal issue that affects one's health but is also a public health issue that impacts other people in society. A new study in the journal Health Services Research reveals that ...

'Lazy eye' discovery of how an old gene learns new tricks

7 hours ago | User rating: not rated yet
(PhysOrg.com) -- Researchers have made a discovery which could lead the way for new treatments into a rare eye disorder which if not treated can result in permanent blindness in childhood.